EUVIMEDEUVIMED entdecken
Crossref

Apolipoprotein E4 (APOE4) as a Modifier of Chemotherapy Response

Hussein N Yassine

The American Journal of Pathology · 2026-09 · 196 (9) · 1837-1838

DOI: 10.1016/j.ajpath.2026.06.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Pathology, 2026-09. Verfasst von Hussein N Yassine. Beteiligte Einrichtung: Neurology and Department of Physiology and Neuroscience, Keck School of Medicine of USC, Los Angeles, California. Electronic address: hyassine@usc.ed…. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Neurology and Department of Physiology and Neuroscience, Keck School of Medicine of USC, Los Angeles, California. Electronic address: hyassine@usc.edu.

Zitieren

APA

Yassine, H. N. (2026). Apolipoprotein E4 (APOE4) as a Modifier of Chemotherapy Response. The American Journal of Pathology, 196(9), 1837-1838. https://doi.org/10.1016/j.ajpath.2026.06.003

Vancouver

Yassine HN. Apolipoprotein E4 (APOE4) as a Modifier of Chemotherapy Response. The American Journal of Pathology. 2026;196(9):1837-1838. doi:10.1016/j.ajpath.2026.06.003

BibTeX
@article{Yassine2026,
  author = {Yassine, Hussein N},
  title = {Apolipoprotein E4 (APOE4) as a Modifier of Chemotherapy Response},
  journal = {The American Journal of Pathology},
  year = {2026},
  volume = {196},
  number = {9},
  pages = {1837--1838},
  doi = {10.1016/j.ajpath.2026.06.003}
}
Kostenlos starten →